Spiny follicular hyperkeratosis eruption: A new cutaneous adverse effect of sorafenib

Journal of Clinical Oncology

Volumn 28, Issue 31, 2010, Pages

  Franck, Nathalie ^a   Barete, Stéphane ^b   Moguelet, Philippe ^b   Blanchet, Benoît ^a   Carlotti, Agnès ^a   Ropert, Stanislas ^a   Avril, Marie Françoise ^a   Francès, Camille ^b   Billemont, Bertrand ^a   Goldwasser, François ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB; ANGIOGENESIS INHIBITOR; BENZENESULFONIC ACID DERIVATIVE; PROTEIN KINASE; PYRIDINE DERIVATIVE;

ADULT; AGED; CHOROID MELANOMA; CLINICAL ARTICLE; DARIER DISEASE; DRUG BLOOD LEVEL; FEMALE; FIBROLAMELLAR HEPATOCARCINOMA; HUMAN; KIDNEY CARCINOMA; LETTER; LIVER CELL CARCINOMA; MALE; MELANOMA; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; THYROID CARCINOMA; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG ERUPTION; FOLLICULITIS; KERATOSIS; MIDDLE AGED; NEOPLASM; PATHOLOGY; SKIN;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BENZENESULFONATES; DRUG ERUPTIONS; FEMALE; FOLLICULITIS; HUMANS; KERATOSIS; MALE; MIDDLE AGED; NEOPLASMS; PROTEIN KINASES; PYRIDINES; SKIN;

EID: 78149250782     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.3783     Document Type: Letter

References (18)

1. Robert C, Mateus C, Spatz A, et al: Dermatologic symptoms associated with the multikinase inhibitor sorafenib. J Am Acad Dermatol 60:299-305, 2009
2. Lacouture ME, Reilly LM, Gerami P, et al: Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Ann Oncol 19:1955-1961, 2008
3. Strumberg D, Richly H, Hilger RA, et al: Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol 23:965-972, 2005 (Pubitemid 46202316)
4. Hong DS, Reddy SB, Prieto VG, et al: Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib. Arch Dermatol 144:779-782, 2008 (Pubitemid 351846880)
5. Arnault JP, Wechsler J, Escudier B, et al: Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib. J Clin Oncol 27:59-61, 2009
6. Blanchet B, Billemont B, Cramard J, et al: Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice. J Pharm Biomed Anal 49:1109-1114, 2009
7. Handa Y, Sakakibara A, Araki M, et al: Spiny keratoderma of the palms and soles - report of two cases. Eur J Dermatol 10:542-545, 2000
8. Mevorah B, Gat A, Golan H, et al: Unilateral spiny hyperkeratosis: Case report and review of the literature. Dermatology 217:181-186, 2008
9. Paul C, Fermand JP, Flageul B, et al: Hyperkeratotic spicules and monoclonal gammopathy. J Am Acad Dermatol 33:346-351, 1995
10. Zarour H, Grob JJ, Andrac L, et al: Palmoplantar orthokeratotic filiform hyperkeratosis in a patient with associated Darier's disease. Classification of filiform hyperkeratosis. Dermatology 185:205-209, 1992
11. Kuokkanen K, Niemi KM, Reunala T, et al: Parakeratotic horns in a patient with myeloma. J Cutan Pathol 14:54-58, 1987 (Pubitemid 17017518)
12. Lukitsch O, Gebhardt KP, Kövary PM, et al: Follicular hyperkeratosis and cryocrystalglobulinemia syndrome: Occurrence in a patient with multiple myeloma. Arch Dermatol 121:795-798, 1985 (Pubitemid 15051674)
13. Osswald SS, Kulick KB, Tomaszewski MM, et al: Viral-associated- trichodysplasia in a patient with lymphoma: A case report and review. J Cutan Pathol 34:721-725, 2007 (Pubitemid 47256249)
14. Horton SL, Hashimoto K, Toi Y, et al: Spiny keratoderma: A common under-reported dermatosis. J Dermatol 25:353-361, 1998 (Pubitemid 28345667)
15. Bachmeyer C, Eacute Milie S, Moguelet P, et al: Filiform palmoplantar hyperkeratosis. Ann Dermatol Venereol 133:827-828, 2006
16. Izakovic J, Büchner SA, Düggelin M, et al: Hair-like hyperkeratoses in patients with kidney transplants: A new cyclosporin side-effect. Hautarzt 46:841-846, 1995
17. Yano K, Brown LF, Detmar M, et al: Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 107:409-417, 2001 (Pubitemid 32167987)
18. Man XY, Yang XH, Cai SQ, et al: Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med 12:127-136, 2006